Race, gender, and safety: exposing biases in minimally invasive lung cancer surgery research

种族、性别与安全:揭露微创肺癌手术研究中的偏见

阅读:2

Abstract

BACKGROUND: Video- and robotic-assisted thoracic surgery are proven safe alternatives to open thoracotomy. But smaller-scale studies examining outcomes between minimally invasive surgery (MIS) and open techniques may fail to capture patterns in health, gender, and race on a national scale. The aim of this study was to identify large-scale trends in the outcomes of MIS in a national database. METHODS: We evaluated adverse events following MIS and open lung resection in the Surveillance, Epidemiology, and End Results (SEER) Medicare database from 1992-2015. RESULTS: A total of 746,441 patients were diagnosed with lung cancer. MIS patients undergoing limited resection (n=5,185) were more likely to be older (74.7 vs. 74.0 years), female (59.4% vs. 52.3%), have adenocarcinoma (62.9% vs. 54.6%), live in an urban area (92.1% vs. 86.2%), and have lower comorbidity scores (10.0 vs. 11.8). MIS patients undergoing lobectomy (n=4,119) were more likely to be older (73.8 vs. 73.1 years), female (57.3% vs. 51.1%), diagnosed at stage I/II (79.8% vs. 75.9%), have adenocarcinoma (63.7% vs. 54.8%), live in an urban area (92.2% vs. 85.2%), and have lower comorbidity scores (8.8 vs. 10.4). Black patients were less likely to receive MIS (4.5% vs. 5.9%). CONCLUSIONS: There are multiple differences between MIS and open surgery, but it is unclear if any confer a clinical benefit. Patients undergoing MIS tend to be healthier with earlier-stage disease, suggesting biases in patient selection. The data suggests that lung cancer should be considered a women's health issue and raises the concern that Black Americans do not have equal access to screening and treatment. While these results support the continued use of MIS, they should not substitute good surgical judgment when open surgery is required.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。